Regrow Biosciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 2.62 Cr
as on 05-07-2024
- Company Age 35 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 22.54 Cr
as on 05-07-2024
- Satisfied Charges ₹ 0.27 M
as on 05-07-2024
- Revenue 9.60%
(FY 2023)
- Profit 40.04%
(FY 2023)
- Ebitda 66.73%
(FY 2023)
- Net Worth -18.18%
(FY 2023)
- Total Assets 5.40%
(FY 2023)
About Regrow Biosciences
The Corporate was formerly known as Regenerative Medical Services Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.62 Cr.
The company currently has active open charges totaling ₹22.54 Cr. The company has closed loans amounting to ₹0.27 M, as per Ministry of Corporate Affairs (MCA) records.
Jill Bhanushali, Gargi Sanghavi, Satyen Sanghavi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100MH1989PTC054162
- Company No.
054162
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 1989
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Regrow Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yash Sanghavi  | Managing Director | 06-Nov-1989 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Satyen Sanghavi | Director | 02-Sep-2008 | Current |
| Jill Bhanushali | Director | 14-Jun-2017 | Current |
| Gargi Sanghavi | Director | 16-Dec-2013 | Current |
| Bhavna Sanghavi | Director | 06-Nov-1989 | Current |
Financial Performance of Regrow Biosciences.
Regrow Biosciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.6% increase. The company also saw a substantial improvement in profitability, with a 40.04% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Regrow Biosciences?
In 2023, Regrow Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Regrow Therapeutics Private LimitedActive 7 years 4 monthsSatyen Sanghavi and Yash Sanghavi are mutual person
Satyan Pharmaceuticals Private LimitedActive 38 years 3 monthsSatyen Sanghavi, Bhavna Sanghavi and 1 more are mutual person
- Biocord Lifescience Private LimitedActive 7 years 12 days
Satyen Sanghavi and Yash Sanghavi are mutual person
Charges (Loans)
₹22.54 Cr
₹0.03 Cr
Charges Breakdown by Lending Institutions
- Canara Bank : 15.24 Cr
- Others : 7.23 Cr
- Kotak Mahindra Prime Limited : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2023 | Others | ₹4.00 Cr | Open |
| 10 Feb 2021 | Others | ₹3.23 Cr | Open |
| 25 Aug 2015 | Kotak Mahindra Prime Limited | ₹0.69 M | Open |
| 03 Aug 2015 | Canara Bank | ₹1.26 Cr | Open |
| 27 Aug 2009 | Canara Bank | ₹8.50 Cr | Open |
How Many Employees Work at Regrow Biosciences?
Regrow Biosciences has a workforce of 95 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regrow Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regrow Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
